` AEMD (Aethlon Medical Inc) vs S&P 500 Comparison - Alpha Spread

AEMD
vs
S&P 500

Over the past 12 months, AEMD has underperformed S&P 500, delivering a return of -69% compared to the S&P 500's +15% growth.

Stocks Performance
AEMD vs S&P 500

Loading
AEMD
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
AEMD vs S&P 500

Loading
AEMD
S&P 500
Difference
www.alphaspread.com

Performance By Year
AEMD vs S&P 500

Loading
AEMD
S&P 500
Add Stock

Competitors Performance
Aethlon Medical Inc vs Peers

Aethlon Medical Inc
Glance View

Market Cap
2.9m USD
Industry
Health Care

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 10 full-time employees. The firm operates through two segments: Aethlon and ESI. The Aethlon segment represents its therapeutic business activities. The ESI segment represents its diagnostic business activities. The firm's product, Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The Aethlon Hemopurifie is designed for the single-use removal of exosomes and life-threatening viruses from the human circulatory system. In cancer, the Aethlon Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression, seed the spread of metastasis. The Company, through its subsidiary Exosome Sciences, Inc. (ESI) is developing exosome-based biomarkers in patients with, or at risk for, a number of cancers.

AEMD Intrinsic Value
2.12 USD
Undervaluation 46%
Intrinsic Value
Price
Back to Top